JPM: Established relationships were key to pandemic drug launches, Incyte CEO says

JPM: Established relationships were key to pandemic drug launches, Incyte CEO says

Source: 
Fierce Pharma
snippet: 

COVID-19 lockdowns last year brought challenges for companies in nearly every industry—including pharmaceutical companies trying to get the word out about new drugs. But for companies with established connections, technology served as a suitable temporary substitute to in-person meetings, Incyte CEO Hervé Hoppenot said in an interview.